Eli Lilly wants to take big swings in Alzheimer’s, ALS, chronic pain and other difficult diseases after its success in ...

ORLANDO, FLA. — Increasing levels of protein and fiber, stressing portion control and adding savory flavors are ways that ...

Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...

Eggs are lean protein and appeal to people taking Ozempic, Wegovy, or other GLP-1 medications. But a big spike in prices has ...

Like Peptide-1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: 68-Market Analysis and Sales Forecast" report has been added to ResearchAndMarkets.com's offering.Across the 68 markets, sales ...

GLP-1 Receptor Agonist Market is estimated to be valued at USD 25.10 Bn in 2024 and is expected to reach USD 55.70 Bn by 2031, exhibiting a CAGR of 12.1%. BURLINGAME, CA, UNITED STATES, February 4 ...

Novo Nordisk has been looking to diversify its lineup in recent years, and is developing medicines in other fields. The ...

Recent polling suggests that approximately 1 in 8 U.S. adults report having ever used a GLP-1 medication. As demand for GLP-1 medications remains steadfast, this survey asked PCPs, who had more ...

MONDAY, Feb. 10, 2025 (HealthDay News) -- Yes, rare cases of vision issues have arisen in people taking popular GLP-1 weight ...

Are you a print subscriber? Activate your account. 39 min 41 sec ago 3 hours 29 min ago By Janelle A. James - 5 hours 19 min ago By Brian Bonilla - 5 hours 49 min ago 1 day 4 hours ago By Ad Age ...